MA52957A - Procédés de fabrication de compositions d'acides aminés - Google Patents

Procédés de fabrication de compositions d'acides aminés

Info

Publication number
MA52957A
MA52957A MA052957A MA52957A MA52957A MA 52957 A MA52957 A MA 52957A MA 052957 A MA052957 A MA 052957A MA 52957 A MA52957 A MA 52957A MA 52957 A MA52957 A MA 52957A
Authority
MA
Morocco
Prior art keywords
processes
manufacturing
amino acid
acid compositions
compositions
Prior art date
Application number
MA052957A
Other languages
English (en)
Inventor
Thomas Hanlon
Denise K Kwok
Daniel Rothenberg
Andrew M Wood
Ralph Yamamoto
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of MA52957A publication Critical patent/MA52957A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA052957A 2018-06-20 2019-06-19 Procédés de fabrication de compositions d'acides aminés MA52957A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
MA52957A true MA52957A (fr) 2021-04-28

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052957A MA52957A (fr) 2018-06-20 2019-06-19 Procédés de fabrication de compositions d'acides aminés

Country Status (17)

Country Link
US (1) US11679089B2 (fr)
EP (1) EP3810168A1 (fr)
JP (1) JP2021529735A (fr)
KR (1) KR20210023846A (fr)
CN (1) CN112823018A (fr)
AR (1) AR115581A1 (fr)
AU (1) AU2019288371A1 (fr)
BR (1) BR112020025831A2 (fr)
CA (1) CA3099762A1 (fr)
CL (1) CL2020003277A1 (fr)
IL (1) IL279328A (fr)
JO (1) JOP20200323A1 (fr)
MA (1) MA52957A (fr)
MX (1) MX2020013732A (fr)
SG (1) SG11202011611XA (fr)
TW (1) TW202015668A (fr)
WO (1) WO2019246201A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
AR115581A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Métodos de preparación de composiciones de aminoácidos
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
JP2024529966A (ja) 2021-07-26 2024-08-14 アクセラ（アサインメント フォ ザ ベネフィット オブ クレディターズ），エルエルシー Ｃｏｖｉｄ－１９の急性期後後遺症の治療に使用するためのアミノ酸組成物及び方法
NL2038264B1 (en) * 2024-07-18 2025-03-06 West China Hospital Sichuan Univ Compound nutritional preparation for reducing fat and increasing muscle and preparation method thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
CA2143420C (fr) 1992-12-23 1999-01-19 Phyllis J. B. Acosta Aliments medicinaux pour le soutien nutritionnel dans les cas de maladies metaboliques chez le nourrisson et le jeune enfant
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (fr) 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
US20040047904A1 (en) * 2001-11-13 2004-03-11 Motohiro Ohta Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same
DE602004001727T2 (de) 2003-04-07 2007-08-02 Novetide Ltd. Verfahren zur herstellung cyclischer peptide
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
EP1699458A4 (fr) 2003-12-30 2012-04-25 Reddys Lab Ltd Dr Composition pharmaceutique
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
JPWO2006062238A1 (ja) 2004-12-07 2008-06-12 味の素株式会社 アミノ酸の微粉末及びその懸濁液
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (fr) * 2009-10-09 2011-04-14 N.V. Nutricia Composition d'acide aminé avec aptitude à la dispersion améliorée
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (fr) * 2013-07-05 2015-01-08 N.V. Nutricia Composition d'acides aminés destinée à être utilisée dans le traitement d'un trouble envahissant du développement
EP3738590A1 (fr) 2013-07-31 2020-11-18 Leeds Beckett University Supplément diététique comprenant des acides aminés pour le traitement de la sarcopénie
EP3048904A2 (fr) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions et formulations pour le traitement des maladies de malabsorption et les affections inflammatoires des voies gastro-intestinales, leurs procédés de production et d'utilisation
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
KR20190005823A (ko) * 2016-02-04 2019-01-16 잡 리써치 앤드 디벨롭먼트, 엘엘씨 제어된-방출 및 혼층 사이클로덱스트린 내포 복합체 비히클
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) * 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
US11617731B2 (en) 2017-04-28 2023-04-04 Axcella Health, Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
JP7370960B2 (ja) 2017-08-14 2023-10-30 アクセラ・ヘルス・インコーポレイテッド 神経細胞損傷の治療のためのアミノ酸組成物
WO2019246310A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions et procédés pour la réduction ou le traitement d'une inflammation
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
JP2021528420A (ja) 2018-06-20 2021-10-21 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 苦味のあるアミノ酸を含む治療及び健康のための組成物
WO2019246298A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions et procédés pour la réduction ou le traitement de la fibrose
WO2019246221A1 (fr) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions et procédés pour le traitement de maladies et troubles hépatiques
JP2021527671A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． インスリン抵抗性及び代謝疾患の軽減又は治療のための組成物及び方法
AR115581A1 (es) 2018-06-20 2021-02-03 Axcella Health Inc Métodos de preparación de composiciones de aminoácidos

Also Published As

Publication number Publication date
US20190388374A1 (en) 2019-12-26
TW202015668A (zh) 2020-05-01
AR115581A1 (es) 2021-02-03
JP2021529735A (ja) 2021-11-04
CA3099762A1 (fr) 2019-12-26
IL279328A (en) 2021-01-31
MX2020013732A (es) 2021-02-26
KR20210023846A (ko) 2021-03-04
EP3810168A1 (fr) 2021-04-28
SG11202011611XA (en) 2021-01-28
CN112823018A (zh) 2021-05-18
US11679089B2 (en) 2023-06-20
WO2019246201A1 (fr) 2019-12-26
JOP20200323A1 (ar) 2020-12-14
BR112020025831A2 (pt) 2021-03-23
CL2020003277A1 (es) 2021-07-09
AU2019288371A1 (en) 2020-12-03

Similar Documents

Publication Publication Date Title
EP4013853A4 (fr) Procédés améliorés de fabrication de compositions organoïdes
EP3934861A4 (fr) Robot d'inspection
EP4083038A4 (fr) Composé pyridazinyl thiazolecarboxamide
EP3615679A4 (fr) Procédés de fabrication d'édulcorants à haute intensité
MA49045A (fr) Compositions et procédés destinés à la distribution régulée d'acide
IL286592A (en) Amino acid compounds for the treatment of liver disease
EP3455895A4 (fr) Compositions et procédés pour la fabrication d'électrode
EP3751001C0 (fr) Procédé de fabrication d'ergothionéine
EP3774338A4 (fr) Procédés et compositions de fabrication additive photopolymérisable
MA42055A (fr) Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci
IL279328A (en) Methods for producing compositions of amino acids
EP3905385A4 (fr) Procédé de fabrication d'électrode
EP3920977A4 (fr) Procédés améliorés d'angiographie
EP3820980A4 (fr) Compositions d'esterquats
MA52417A (fr) Procédés de modification de composition corporelle
EP3645548A4 (fr) Procédés de préparation d'acides biliaires
EP3467113A4 (fr) Procédé de fabrication d'acide a-hydromuconique
EP3353148A4 (fr) Procédés de fabrication d'intermédiaires d'onapristone
EP3476943A4 (fr) Procédé de fabrication d'acide polyhydroxyalcanoïque
EP3769361A4 (fr) Procédés de fabrication de nanopuits de biocapteur
EP3750173A4 (fr) Procédés de fabrication d'un supraconducteur
IL290181A (en) Process for the preparation of fluensulfone
ZA202105229B (en) Amino acid derivatives for the treatment of inflammatory diseases
EP3968789C0 (fr) Procédés d'encapsulation
EP3762503A4 (fr) Séparation d'acides aminés basiques